Issue 111 • October 2021

Fighting cancer with bacteria

Could llamas help treat Covid-19?

Securing the US API supply chain

In association with

Unpacking innovation in biologics 

Modern biologics are highly complex and require packaging solutions that can ensure the stability of medication throughout its shelf life

In association with

09/23/2021 09:54:30
  • Home | Unpacking innovation in biologics 
  • In this issue
  • Contents
  • Myonex
  • Controlant Company Insight
  • Controlant
  • SHL Medical
  • Labcorp
  • Reuters
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Covid-19 executive briefing by GlobalData
  • Mimotopes Company Insight
  • Mimotopes
  • TQS Integration Company Insight
  • TQS Intergration
  • Biesterfeld
  • Comment
  • Biotech and China: a global opportunity
  • Intranasal ketamine could effectively treat phantom pain
  • EU biosimilar wave slows as biosimilar approvals decrease in the EU
  • Biosynth Carbosynth Company Insight
  • Biosynth Carbosynth
  • Molnár-Institute Company Insight
  • Molnar-Institute
  • Skyepharma
  • In Depth
  • Unpacking the complex challenge of biologics
  • Living medicines: using bacteria to fight cancer
  • The marred history of HIV vaccine trials
  • Has Covid-19 exposed the weakness of the US pharma supply chain?
  • How the pandemic pushed pharmacovigilance to innovate
  • ExeVir: the llama-derived antibody that could fight Covid-19
  • BEA Technologies
  • Watlow
  • Duoject
  • Butterworth
  • In Data
  • Data: Big Data hiring efforts in pharma
  • The pharma industry key list
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • Events
  • Next issue